Adicet bio to participate in a fireside chat at the 45th annual canaccord genuity growth conference

Redwood city, calif. & boston--(business wire)--adicet bio, inc. (nasdaq: acet), a clinical stage biotechnology company discovering and developing allogeneic gamma delta t cell therapies for autoimmune diseases and cancer, today announced that chen schor, president and chief executive officer, will participate in a fireside chat at the 45th annual canaccord genuity growth conference being held from august 12-14, 2025 in boston. details of the event are as follows: date: tuesday, august 12, 2025.
ACET Ratings Summary
ACET Quant Ranking